Company Changes (6/02)

ANANIA, Joseph

To: Verimetra Inc., CFO(Jun.)

From: UPMC Health System, Dir., Corp. Dev.

Tel: [phone]

BERNS, Paul L.

To: Bone Care International Inc., Pres. & CEO(Jun.)

From: Abbott Laboratories Inc., VP, GM, Immunology & Oncology

Tel: [phone]

BOULDING, Mark

To: PTC Therapeutics Inc., SVP, Bus. Dev. & Legal(Apr.)

From: MedicaLogic/Medscape Inc., EVP, General Counsel

Tel: [phone]

CANTILLON, Marc, MD

To: Impax Laboratories Inc., VP, Clinical Dev.(May)

From: Wyeth-Ayerst, (now Wyeth), Global Therapeutics Area, Dir., Neuroscience

Tel: [phone]

CHELSKY, Daniel

To: Caprion Pharmaceuticals Inc., EVP, CSO(May)

From: BioSignal Packard Inc., Pres. & GM

Tel: [phone]

DIDSBURY, John, PhD

To: ChemCodes, Pres. & CEO(May)

From: GlaxoSmithKline PLC, Head, Strategy & Oper., Drug Discovery Unit

Tel: [phone]

DINGER III, Fred B.

To: OsteoBiologics Inc., Pres. & CEO(Jun.)

From: A-Med Systems Inc., COO

Tel: [phone]

DOWSETT, David

To: The Med-Design Corp., EVP, COO(Jun.)

From: Becton Dickinson & Co., Dir., Bus.

Tel: [phone]

ELLIOT, David

To: VMBC LLC, Pres. & CEO(May)

From: Advanced Respiratory Inc., VP, Sales & Mktg.

Tel: [phone]

ERWIN, Wood C.

To: TargeGen Inc., VP, Fin. & CFO(Jun.)

From: Maxia Pharmaceuticals Inc., VP, Fin. & CFO

Tel: [phone]

FLAVIN, John L.

To: Advanced Life Sciences Inc., CFO(Jun.)

From: MediChem Life Sciences Inc., COO

Tel: [phone]

GATHMAN, David D.

To: Targeted Diagnostics & Therapeutics Inc., VP, CFO(May)

From: Federal Reserve Bank of Philadelphia, SVP, CFO

Tel: [phone]

GIFFIN, Christopher

To: Protein Pathways Inc., VP, Bus. Dev.(May)

From: Consultant, Bench International Search Inc.

Tel: [phone]

HAMELIN, Paul

To: Elitra Pharmaceuticals Inc., Pres. & COO(Jun.)

From: Millennium Pharmaceuticals Inc., SVP, Global Commercial Oper.

Tel: [phone]

Executive Recruiter: Strawn Arnold Leech & Ashpitz Inc.

HANLON, John J.

To: Pharmacopeia Inc., EVP, CFO(Jun.)

From: Digital Courier Technologies Inc., Pres. & CFO

Tel: [phone]

HAZELWOOD, Vikki A.

To: Memry Corp., VP, Sales & Mktg.(May)

From: Hydromer Inc., Mgr., Strategic Bus. Unit, Medical Devices Div.

Tel: [phone]

HEILBRUNN, Kenneth, R., MD

To: La Jolla Pharmaceutical Co., VP, Clinical Dev.(Jun.)

From: Advanced Tissue Sciences Inc., VP, Clinical Research

Tel: [phone]

HETHERINGTON, Seth V., MD

To: Inhibitex Inc., VP, Clinical Affairs & CMO(Jun.)

From: GlaxoSmithKline PLC, Dir., & Clinical Matrix Team Leader, Infectious Diseases

Tel: [phone]

KRUKA, William C.

To: Caliper Technologies Corp., VP, Bus. Dev.(May)

From: Applied Biosystems Group, Sr. Mgr., Bus. Dev.

Tel: [phone]

LANE, Richard J.

To: Andrx Corp., CEO(Jun.)

From: Bristol-Myers Squibb Co., Pres., Worldwide Medicines Group

Tel: [phone]

LEHMAN, Lori, PhD

To: Third Wave Technologies Inc., VP, Bus. Dev., Genomics Bus. Unit(Jun.)

From: Argonaut Technologies Inc., VP, Bus. Dev.

Tel: [phone]

LEVITT, Daniel J., MD, PhD

To: Affymax Inc., Head, R&D & COO(Jun.)

From: Protein Design Labs, Pres., R&D

Tel: [phone]

LEWIS, Dean P.

To: Panacea Pharmaceuticals Inc., CFO(Jun.)

From: Consultant

Tel: [phone]

LONGENECKER, John P., PhD

To: Favrille Inc., CEO(Mar.)

From: SkyePharma Inc., Pres.

Tel: [phone]

MACDONALD, Cameron, PhD

To: Gene Expression Technologies Ltd., CEO(Apr.)

From: PanTherix Ltd., CEO

Tel: [phone]

MATTYS, Gerald R.

To: Medisyn Technologies Inc., CEO(Jun.)

From: Timm Medical Technologies Inc., Pres. & CEO

Tel: [phone]

Executive Recruiter: Andcor Companies Inc.

MATYSIK, Mike

To: Quinton Cardiology Systems Inc., SVP, CFO(May)

From: DMX Music, EVP, CFO

Tel: [phone]

McKELVY, Jeffrey, F., PhD

To: Avera Pharmaceuticals Inc., Pres. & CEO(May)

From: Merck Research Laboratories, VP & Site Head

Tel: [phone]

MOORE, Alan F., PhD

To: Cardiome Pharma Corp., EVP, Clinical Dev. & Reg. Affairs(May)

From: Procter & Gamble Pharmaceuticals, GM, Cardiac R&D

Tel: [phone]

MYERS, Peter, PhD

To: Libraria Inc., CEO(Jun.)

From: Deltagen Research Laboratories, EVP, Site Dir.

Tel: [phone]

NEAL, Jim

To: Iconix Pharmaceuticals Inc., CEO(Jun.)

From: Incyte Genomics Inc., EVP, Sales & Mktg. & Bus. Dev.

Tel: [phone]

ORGAN, Jeffrey

To: Tanox Inc., COO(May)

From: Consultant

Tel: [phone]

POLISKY, Barry A., PhD

To: Ribozyme Pharmaceuticals Inc., VP, Research(Jun.)

From: ThermoBiostar Inc., VP, Research

Tel: [phone]

POLVINO, William J., MD

To: Rejuvenon Corp., SVP, Clinical Dev.(May)

From: Theravance Inc., VP, Clinical Affairs & Acting Head, Dev.

Tel: [phone]

POWELL, Fred

To: Zarix Inc., CFO(Jun.)

From: InnaPhase, SVP, Fin. & Admin.

Tel: [phone]

RANDALL, Lorin Jeffry

To: i-Stat Corp., SVP, Fin. & CFO(May)

From: CFM Technologies Inc., VP, CFO

Tel: [phone]

SAXENA, Uday, PhD

To: Dr. Reddy's Laboratories, CSO(Jun.)

From: Reddy US Therapeutics Inc., Pres.

Tel: [phone]

THORNTON, Steven

To: SkyePharma Inc., Pres.(May)

From: Elan Pharmaceutical Technologies, EVP, Commercial Dev.

Tel: [phone]

WASKO, Stephen G.

To: Molecular Diagnostics Inc., Pres. & COO(Jun.)

From: Perceptual Robotics Inc., Chief Fin. & Bus. Dev. Officer

Tel: [phone]

WEAVER, Gregory L.

To: Nastech Pharmaceutical Co. Inc., CFO(May)

From: Ilex Oncology Inc., VP, Strategic Dev. & CFO

Tel: [phone]

WEBER, Gary A.

To: Synthetech Inc., VP, Fin. & Admin.(Jun.)

From: Wah Chang, VP, Fin.

Tel: [phone]

WONNACOTT, David M., PhD

To: Inhibitex Inc., VP, Quality & Reg. Affairs(May)

From: Aviron Inc., VP, Reg. Affairs

Tel: [phone]

VALLET, Jean-Marie, PhD

To: Guilford Pharmaceuticals Inc., VP, Bus. Dev.(May)

From: Valigen Inc., Pres., Human Healthcare

Tel: [phone]

YARRANTON, Geoffrey T., PhD

To: Deltagen Inc., EVP, R&D(May)

From: Corixa Corp., SVP, R&D

Tel: [phone]